18F-FDG and 68Ga-FAPI-04 PET/CT in Evaluating Clear-Cell Endometrial Cancer.

Kiran M. Y., Has Simsek D., Sanli Y., Kuyumcu S.

Clinical nuclear medicine, cilt.48, sa.2, 2023 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 48 Sayı: 2
  • Basım Tarihi: 2023
  • Doi Numarası: 10.1097/rlu.0000000000004532
  • Dergi Adı: Clinical nuclear medicine
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE
  • İstanbul Üniversitesi Adresli: Evet

Özet

A 60-year-old woman diagnosed with clear cell endometrial carcinoma received neoadjuvant chemotherapy. However, the patient was inoperable and referred to our clinic to evaluate the extent of the disease. The patient underwent (18)FDG PET/CT and Ga-68-FAPI (fibroblast activated protein inhibitor)-04 PET/CT scans. Ga-68-FAPI-04 PET/CT outperformed (18)FDG PET/CT demonstrating higher uptake in the metastatic lesions.